What is the recommended diagnostic test for brucellosis (Brucella infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Brucellosis

The recommended diagnostic approach for brucellosis is serological testing with an ELISA screening followed by a confirmatory agglutination test, with blood cultures performed simultaneously to establish a definitive diagnosis. 1

Primary Diagnostic Methods

Serological Testing

  • In non-endemic areas:

    • Initial ELISA screening for IgM and IgG antibodies
    • Followed by confirmatory standard tube agglutination test (SAT) 1
    • Positive titer cutoff: ≥1:160 1, 2
  • In endemic areas:

    • Serum agglutination test (SAT) or microagglutination test (MAT) may be used directly 1, 3
    • Strongly positive Brucella serology (titers ≥1:160) may be sufficient for diagnosis without additional testing 4

Blood Culture

  • Should be performed simultaneously with serological testing 2
  • Sensitivity ranges from 15-70% depending on:
    • Laboratory practices
    • Bacterial load in blood
    • Culture methods used 2
  • Definitive diagnosis requires isolation of Brucella from blood, bone marrow, or tissue samples 2

Special Considerations

Bone Marrow Culture

  • Considered the gold standard for diagnosis of brucellosis 2
  • Higher sensitivity than blood culture due to higher concentration of Brucella in reticuloendothelial system
  • Should be considered when blood cultures are negative but clinical suspicion remains high

PCR Testing

  • Rapid molecular method with high sensitivity and specificity 5, 6
  • Particularly useful in early stages of infection before antibody development
  • Can detect Brucella DNA in serum samples 5, 6
  • May yield positive results when cultures are negative, especially if antibiotics have been started

Diagnostic Algorithm

  1. Initial Assessment:

    • Obtain detailed history (animal contact, consumption of unpasteurized dairy, travel to endemic regions)
    • Evaluate for compatible clinical presentation (fever, arthralgia, hepatosplenomegaly)
  2. First-line Testing:

    • Blood cultures (at least 2 sets)
    • Serological testing:
      • ELISA for IgM and IgG (in non-endemic areas)
      • SAT or MAT (in endemic areas)
  3. Interpretation:

    • Positive diagnosis if:
      • Positive blood culture for Brucella species, OR
      • Serological titer ≥1:160 with compatible clinical picture 1, 2
  4. Additional Testing (if initial tests inconclusive):

    • Bone marrow culture (if blood cultures negative)
    • PCR testing of blood/serum
    • Repeat serological testing in 2-4 weeks if initial results are negative but clinical suspicion remains high

Common Pitfalls and Caveats

  • False-negative serology: May occur early in infection, with "blocking" antibodies, or due to the "prozone" phenomenon 2

    • Solution: Repeat testing or use alternative methods like ELISA or Coombs' test
  • False-positive serology: Can occur with cross-reacting antibodies from other infections

    • Solution: Confirmatory testing with more specific methods
  • Culture limitations: Brucella is slow-growing and requires special culture conditions

    • Solution: Inform laboratory of clinical suspicion for brucella to ensure appropriate culture techniques
  • Vertebral osteomyelitis (NVO): In patients with suspected brucellar NVO:

    • Image-guided aspiration biopsy is not necessary if blood cultures are positive for Brucella or if serology is strongly positive in endemic areas 4, 1
    • MRI is mandatory when spinal involvement is suspected 1

The microagglutination test (MAT) has shown excellent correlation with ELISA, with sensitivity and specificity of 93.3% and 96.7% for IgG and 96.7% and 98.3% for IgM, respectively 3. This test requires less time, antigen, and serum than the standard tube agglutination test, making it a practical alternative in resource-limited settings.

References

Guideline

Brucella Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.